17 June 2021
Latham & Watkins Advises the Underwriters in Lyell Immunopharma’s US$425 Million IPO
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brian Cuneo Lead | Latham & Watkins LLP | Partner | capital markets | Bay Area |
| Shayne Kennedy Lead | Latham & Watkins LLP | Partner | capital markets | Orange County |
| Raul Gonzalez | Latham & Watkins LLP | Associate | capital markets | Bay Area |
| Melinda Vanderburg | Latham & Watkins LLP | Associate | capital markets | Bay Area |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory matters | Washington, D.C. |
| Nathan Beaton | Latham & Watkins LLP | Associate | FDA regulatory matters | Washington, D.C. |
| Lacey Henry | Latham & Watkins LLP | Associate | FDA regulatory matters | New York |
| Betty Pang | Latham & Watkins LLP | Counsel | healthcare regulatory matters | Bay Area |
| Judith Hasko | Latham & Watkins LLP | Partner | intellectual property matters | Bay Area |
| Peggy Ni | Latham & Watkins LLP | Associate | intellectual property matters | Bay Area |
| Heather Deixler | Latham & Watkins LLP | Counsel | data privacy matters | Bay Area |
| Grace Lee | Latham & Watkins LLP | Partner | tax matters | Bay Area |
| Gregory Conyers | Latham & Watkins LLP | Associate | tax matters | Bay Area |
| James Metz | Latham & Watkins LLP | Partner | benefits and compensation matters | Bay Area |
| Samantha Voutyras | Latham & Watkins LLP | Associate | benefits and compensation matters | Chicago |
12 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 425m (US$425 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Lyell Immunopharma, Inc. (Issuer)